Without COVID, AT1 made 3.04m revenue last FY, even with the market cap today, it has a price/sales ratio of 32.7. I wouldn't call that a bargain price...COVID also gave AT1 an opportunity to expand its market awareness and form new partnerships, which AT1 failed to do so.
With the management, all I can say is when was Pantonic's self-antigen test approved again?
HIV self-test market is extremely limited unless it can go worldwide
Another thing you need to think about is that it went up from 18cents to 37cents based on what? I believe it was mostly antigen testing hype, nothing material, so that is why it came down to this level again. The business has not changed
Without COVID, AT1 made 3.04m revenue last FY, even with the...
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
0.001(3.33%) |
Mkt cap ! $19.81M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.1¢ | 2.9¢ | $4.745K | 159.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 123968 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 53324 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
3.1¢ |
Change
0.001 ( 3.33 %) |
||||
| Open | High | Low | Volume | ||
| 3.0¢ | 3.1¢ | 2.9¢ | 32795 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| AT1 (ASX) Chart |